Mouse foot screen for the inhibition of sweating by anticholinergic drugs.
D000818:Animals; D003510:Cyclohexanes / Q000008:administration & dosage / Q000494:pharmacology; D003517:Cyclopentanes / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006614:Hindlimb; D006919:Hydroxyzine / Q000008:administration & dosage / Q000494:pharmacology; D007279:Injections, Subcutaneous; D008297:Male; D008722:Methods; D051379:Mice; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D010862:Pilocarpine / Q000494:pharmacology; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology; D011437:Propylamines / Q000008:administration & dosage / Q000494:pharmacology; D011758:Pyrroles / Q000008:administration & dosage / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D012601:Scopolamine / Q000008:administration & dosage / Q000494:pharmacology; D013546:Sweating / Q000187:drug effects*
D003510:Cyclohexanes; D003517:Cyclopentanes; D010276:Parasympatholytics; D011412:Propanolamines; D011437:Propylamines; D011758:Pyrroles; D000644:Quaternary Ammonium Compounds; D010862:Pilocarpine; D006919:Hydroxyzine; D012601:Scopolamine